Source: Korea Biomedical Review

ILDong: Ildong Pharmaceutical establishes new subsidiary to boost profitability, R&D

Ildong Pharmaceutical said on Wednesday that it will separate its research and division (R&D) department and establish a subsidiary to boost profitability and R&D.Ildong Pharmaceutical will maintain a 100 percent stake in the new company as the parent company. The tentative name of the corporation i

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Lee Jung-chi's photo - CEO of ILDong

CEO

Lee Jung-chi

CEO Approval Rating

66/100

Read more